Arthur Weiss

Arthur Weiss

Auto-generated profile, based on publicly available information

Arthur Weiss

Departments of Medicine, Microbiology and Immunology, University of California, San Francisco

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2004 in Oncogene
Verified
Journal Article
Closed access
EPEmil H Palacios
Emil H Palacios
AWArthur Weiss
Arthur Weiss

1 February 2018 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
ACAdam Heath Courtney
Adam Heath Courtney
WLWan-Lin Lo
Wan-Lin Lo
AWArthur Weiss
Arthur Weiss

1 January 2009 in Cell
Verified
Journal Article
Closed access
JDJayajit Das
Jayajit Das
MHMary Ho
Mary Ho
JZJulie Zikherman
Julie Zikherman
CGChristopher Govern
Christopher Govern
MYMing Yang
Ming Yang
Jeroen RooseJeroen Roose
Jeroen Roose

1 May 2010 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
HWHaopeng Wang
Haopeng Wang
TKTheresa A. Kadlecek
Theresa A. Kadlecek
BAByron B. Au-Yeung
Byron B. Au-Yeung
HGHanna E. Sjölin Goodfellow
Hanna E. Sjölin Goodfellow
LHLih-Yun Hsu
Lih-Yun Hsu
AWArthur Weiss
Arthur Weiss
ZAP-70 is a cytoplasmic protein tyrosine kinase that plays a critical role in the events involved in initiating T-cell responses by the antigen receptor. Here we review the structure of ZAP-70, its regulation, its role in development and in disease. We also describe a model experimental system in which ZAP-70 function can be interrupted by a small chemical inhibitor.

19 August 2014 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
ACArup K Chakraborty
Arup K Chakraborty
AWArthur Weiss
Arthur Weiss

19 August 2012 in Nature
Verified
Journal Article
Open access
PDF file
JZJulie Zikherman
Julie Zikherman
RPRamya Parameswaran
Ramya Parameswaran
AWArthur Weiss
Arthur Weiss
Mature B cells encounter antigens during development that induce anergy or functional unresponsiveness; this large reservoir of dormant autoreactive B cells may serve as a pool of extended antibody specificity for purposes of protective immunity, as well as the source of pathogenic autoantibodies that characterize rheumatic diseases such as systemic lupus erythematosus. This study demonstrates that B cells encounter autoantigens during development and that autoreactive B cells persist in the mature repertoire, but become less responsive or anergic to B-cell antigen-receptor stimulation, thereby avoiding autoimmunity. Autoreactivity seems to correlate with the threshold of B-cell activation so that only foreign antigens interacting with B cells at a level greater than the cells' inherent autoreactivity will be activated. The authors speculate that this large reservoir of dormant autoreactive B cells may act as a source of pathogenic autoantibodies in rheumatic diseases such as systemic lupus erythematosus. In humans, up to 75% of newly generated B cells and about 30% of mature B cells show some degree of autoreactivity1. Yet, how B cells establish and maintain tolerance in the face of autoantigen exposure during and after development is not certain. Studies of model B-cell antigen receptor (BCR) transgenic systems have highlighted the critical role of functional unresponsiveness or ‘anergy’2,3. Unlike T cells, evidence suggests that receptor editing and anergy, rather than deletion, account for much of B-cell tolerance4,5. However, it remains unclear whether the mature diverse B-cell repertoire of mice contains anergic autoreactive B cells, and if so, whether antigen was encountered during or after their development. By taking advantage of a reporter mouse in which BCR signalling rapidly and robustly induces green fluorescent protein expression under the control of the Nur77 regulatory region, antigen-dependent and antigen-independent BCR signalling events in vivo during B-cell maturation were visualized. Here we show that B cells encounter antigen during development in the spleen, and that this antigen exposure, in turn, tunes the responsiveness of BCR signalling in B cells at least partly by downmodulating expression of surface IgM but not IgD BCRs, and by modifying basal calcium levels. By contrast, no analogous process occurs in naive mature T cells. Our data demonstrate not only that autoreactive B cells persist in the mature repertoire, but that functional unresponsiveness or anergy exists in the mature B-cell repertoire along a continuum, a fact that has long been suspected, but never yet shown. These results have important implications for understanding how tolerance in T and B cells is differently imposed, and how these processes might go awry in disease.